Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP1 | P09874 | 1/20 | 0.41 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.38 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.38 |
| ▸ | NNMT | P40261 | 2/20 | 0.38 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | IRAK1 | P51617 | 2/20 | 0.37 |
| ▸ | IRAK4 | Q9NWZ3 | 7/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | GLA | P06280 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.35 |
| ▸ | MGMT | P16455 | 1/20 | 0.35 |
| ▸ | QPCT | Q16769 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30640970 | 0.85 | GAA (0.40) | PDPK1ALDH1A1KDM4EGAAQPCT | |
| SCHEMBL3731437 | 0.74 | PDPK1 (0.43) | PDPK1ALDH1A1KDM4EQPCT | |
| SCHEMBL25349620 | 0.73 | PDPK1 (0.42) | PDPK1ALDH1A1KDM4EHPGDRXFP1 | |
| SCHEMBL30798586 | 0.72 | QPCT (0.50) | PARP1POLBALDH1A1KDM4EGLA | |
| SCHEMBL1975515 | 0.69 | QPCT (0.50) | PARP1POLBIRAK4ALDH1A1KDM4E | |
| SCHEMBL2009043 | 0.68 | PARP1 (0.44) | PARP1NNMTALDH1A1KDM4EHPGD | |
| SCHEMBL30640966 | 0.68 | PARP1 (0.44) | PARP1NNMTALDH1A1KDM4EHPGD | |
| SCHEMBL8639128 | 0.67 | KDM4E (0.52) | PARP1ALDH1A1KDM4EHPGDQPCT | |
| SCHEMBL12611466 | 0.67 | NNMT (0.46) | NNMTPOLBALDH1A1KDM4EGLA | |
| SCHEMBL8247379 | 0.66 | SLC9A1 (0.47) | ROCK2ROCK1NNMTPOLBALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230271956-A1 | AMIDE DERIVATIVES | MERCK PATENT GMBH (DE) | 2023-08-31 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230271956-A1 | AMIDE DERIVATIVES | BRCA1, HRAS, PCNA | PARP1 524/4885ROCK2 2287/4885ROCK1 2381/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.